Qingdao Vland Biotech Co Ltd (603739) — Capital Reinvestment Ratio
Latest as of September 2025:
0.31x
Qingdao Vland Biotech Co Ltd (603739) has a Capital Reinvestment Ratio of 0.31x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥24.29 Million) in capital expenditures (CN¥7.42 Million). See Qingdao Vland Biotech Co Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.31x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥24.29 Million
CNY
Capital Expenditures
CN¥7.42 Million
CNY
Data as of
Sep 2025
Most recent filing
Qingdao Vland Biotech Co Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Qingdao Vland Biotech Co Ltd's Capital Reinvestment Ratio across 11 annual periods.
Annual Capital Reinvestment Ratio for Qingdao Vland Biotech Co Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Qingdao Vland Biotech Co Ltd from 2014 to 2024. For live market cap and broader valuation context, see 603739 market cap.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.54x | CN¥195.41 Million | CN¥104.72 Million | ▼ -61.8% |
| 2023 | 1.40x | CN¥153.59 Million | CN¥215.64 Million | ▼ -60.9% |
| 2022 | 3.59x | CN¥95.31 Million | CN¥342.02 Million | ▼ -34.9% |
| 2021 | 5.51x | CN¥89.51 Million | CN¥493.58 Million | ▲ +350.3% |
| 2020 | 1.22x | CN¥173.00 Million | CN¥211.83 Million | ▼ -33.4% |
| 2019 | 1.84x | CN¥65.33 Million | CN¥120.17 Million | ▲ +120.4% |
| 2018 | 0.83x | CN¥85.75 Million | CN¥71.56 Million | ▲ +75.3% |
| 2017 | 0.48x | CN¥121.90 Million | CN¥58.05 Million | ▲ +177.1% |
| 2016 | 0.17x | CN¥154.49 Million | CN¥26.55 Million | ▼ -76.9% |
| 2015 | 0.74x | CN¥74.27 Million | CN¥55.32 Million | ▼ -14.4% |
| 2014 | 0.87x | CN¥58.55 Million | CN¥50.93 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow